Identification of high-risk chronic heart failure patients in clinical practice: role of changes in left ventricular function.

about

Identification of high-risk chronic heart failure patients in clinical practice: role of changes in left ventricular function.

Item

http://www.wikidata.org/entity/Q43907909

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Identification of high-risk ch ...... in left ventricular function.

@en

Identification of high-risk ch ...... in left ventricular function.

@nl

type

Item

label

Identification of high-risk ch ...... in left ventricular function.

@en

Identification of high-risk ch ...... in left ventricular function.

@nl

prefLabel

Identification of high-risk ch ...... in left ventricular function.

@en

Identification of high-risk ch ...... in left ventricular function.

@nl

P1476

Identification of high-risk ch ...... s in left ventricular function

@en

P2093

Andrea Chiampan

http://www.w3.org/2001/XMLSchema#string

Andrea Rossi

http://www.w3.org/2001/XMLSchema#string

Corinna Bergamini

http://www.w3.org/2001/XMLSchema#string

Corrado Vassanelli

http://www.w3.org/2001/XMLSchema#string

Giulia Frigo

http://www.w3.org/2001/XMLSchema#string

Mariantonietta Cicoira

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.

Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.

Left ventricular dysfunction: causes, natural history, and hopes for reversal.

Controversies in ventricular remodelling.

P304

580-584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.22024

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

L Zanolla

Marzia Rigolli

P577

2012-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227177842

http://www.w3.org/2001/XMLSchema#string

P698

22707317

http://www.w3.org/2001/XMLSchema#string

P932

6652648

http://www.w3.org/2001/XMLSchema#string